Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical
Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for investors. Learn more on SYK stock here.
Device maker Stryker strikes $4.9 billion deal for Inari Medical
Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after the bell Monday.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker strikes $4.9B deal to buy Inari Medical
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.
Stryker to acquire medical device company for $4.9B
Stryker has entered a definitive agreement to acquire medical device company Inari Medical for approximately $4.9 billion. Inari was founded in 2011 and focuses on mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism, according to a Jan. 6 press release.
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80 per share in cash,
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
Stryker Corporation SYK recently inked a definitive agreement to acquire all the issued and outstanding shares of common stock of Inari Medical, Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.
Hosted on MSN1d
Earnings Preview: What to Expect from Stryker’s Report
Portage, Michigan-based Stryker Corporation (SYK) offers innovative products and services in MedSurg, Neurotechnology, ...
Stryker’s (SYK) “Market Perform” Rating Reiterated at JMP Securities
JMP Securities reissued their market perform rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued ...
Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
BTIG Sticks to Their Buy Rating for Stryker (SYK)
BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...
crainsgrandrapids4d
Stryker plans $4.9 billion offer to acquire California medical device firm
Stryker Corp. plans to pay $4.9 billion to acquire Inari Medical Inc., which makes devices to treat venous conditions.
Stryker (NYSE:SYK) Receives “Buy” Rating from Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Stryker (NYSE:SYK – Free Report) in a report released on Tuesday,Benzinga reports. The firm currently has a $442.00 price objective on the ...